Title Monometalni i heterobimetalni kompleksi N-heterocikla – sinteza, strukturna karakterizacija i biološka ispitivanja
Title (english) Monometallic and heterobimetallic complexes of N-heterocycles – synthesis, structural characterization and biological evaluation
Author Silvio Jakopec
Mentor Silvana Raić-Malić (mentor)
Mentor Srećko Kirin (mentor)
Committee member Tatjana Gazivoda Kraljević (predsjednik povjerenstva)
Committee member Marijana Hranjec (član povjerenstva)
Committee member Maja Majerić-Elenkov (član povjerenstva)
Granter University of Zagreb Faculty of Chemical Engineering and Technology Zagreb
Defense date and country 2023-04-12, Croatia
Scientific / art field, discipline and subdiscipline NATURAL SCIENCES Chemistry Organic Chemistry
Universal decimal classification (UDC ) 54 - Chemistry. Crystallography. Mineralogy
Abstract U okviru disertacije proučavani su N-heterociklički ligandi i njihovi metalni kompleksi. Provedena je sinteza heterocikličkih spojeva, poput derivata piridina, 2,2'-dipiridilamina, benzimidazola i benzotiazola, koji sadrže monodentatne, bidentatne i tridentatne koordinirajuće skupine, te njihovih koordinacijskih kompleksa s prijelaznim metalima. Pripravljeni derivati podijeljeni su u šest klasa. Bidentatni i tridentatni heterociklički ligandi sintetizirani su višestupnjevitom sintezom primjenom konvencionalnih sintetskih metoda i reakcijama „zelene“ kemije potpomognutih mikrovalovima. Strukture ligadana i metalnih kompleksa potvrđene su spetroskopskopijom NMR, IR i UV, te difrakcijom rendgenskog zračenja u jediničnom kristalu, a heterobimetalni kompleksi karakterizirani su voltametrijski te računalnom analizom. Pripravljenim ligandima i metalnim kompleksima ispitano je antiproliferativno djelovanje na niz tumorskih staničnih linija in vitro, kao i na zdrave stanice uz referentne kliničke lijekove. Koordinacija metalom poboljšala je antitumorsku aktivnost i selektivnost u većini slučajeva. Heterobimetalni kompleks konjugata ferocena i
2,2'-dipiridilamina s bakrom(II) [Cu(A8c)2](CF3SO3)2 pokazao je selektivno inhibitorno djelovanje na stanice HeLa, MES-OV, A549 i MDA-MB-231 uz povećanje stanične populacije u fazama staničnog ciklusa S i G2/M. Aktivnost 2,2'-dipiridilaminskih kompleksa poboljšana je koordinacijom s Re(I), pri čemu je najizraženiju aktivnost, bolju u odnosu na cisplatinu, pokazao kompleks [Re(B4a)(CO)3]Cl. Kompleks strukturno fleksibilnijeg
bis(2,2'-pikolil)aminskog liganda i Ni(II), [Ni(C1)2](NO3)2, pokazao je istaknuto antiproliferativno djelovanje ometajući proces replikacije DNK i smanjujući ekspresiju antiapoptotskog markera Bcl-2. Rutenijevi(II) polusendvič kompleksi 2-arilbenzotiazola i 2-pikolila povezani 1,2,3-triazolnom premosnicom imali su antiproliferativno djelovanje u submikromolarnom području, pokazujući selektivnost prema PANC1 stanicama. Konjugati acil-tiourea i benzotiazola te njihovi Ru(II) kompleksi imali su inhibitorno djelovanje u niskom mikromolarnom i nanomolarnom području na stanice H460, MCF-7, SW 620 i HepG2, s izraženim djelovanjem na staničnoj liniji raka dojke (MCF-7). Spojevi su, osim toga, pokazali slabo do umjereno antibakterijsko djelovanje prema E. faecalis. Ligand E5c i kompleksi D4aRu, E4cRu i E5cRu odabrani su za daljnja testiranja mehanizma biološkog djelovanja.
Abstract (english) In this dissertation, selected N-heterocyclic ligands and their metal complexes were studied. The synthesis of heterocyclic compounds, such as derivatives of pyridine,
2,2'-dipyridylamine, benzimidazole and benzothiazole, containing monodentate, bidentate and tridentate coordinating groups, and their coordination complexes with transition metals was carried out. The prepared derivatives are divided into corresponding six classes. The bidentate and tridentate heterocyclic ligands were synthesized by multi-step synthesis using conventional synthetic methods and „green“ microwave-assisted synthesis. The structures of the ligands and metal complexes were confirmed by NMR, UV and IR-spectroscopy and single-crystal X-ray diffraction. Heterobimetallic complexes were additionally characterized by voltammetry and computational analysis. The prepared ligands and metal complexes were evaluated for their antiproliferative activity in vitro against several tumor cell lines, as well as on normal cells with clinical drugs as references. Generally, metal coordination improved activity and selectivity in most cases. The heterobimetallic complex of ferrocene and
2,2'-dipyridylamine conjugate with copper(II) [Cu(A8c)2](CF3SO3)2 showed a selective inhibitory effect on HeLa, MES-OV, A549 and MDA-MB-231 cells with an increase in cell population in the S and G2/M phase of the cell cycle. The activity of 2,2'-dipyridylamine complexes was improved by coordination with Re(I), where [Re(B4a)(CO)3]Cl showed the most pronounced activity, better than cisplatin. The Ni(II) complex of the more structurally flexible bis(2,2'-picolyl)amine ligand, [Ni(C1)2](NO3)2, showed prominent antiproliferative activity by interfering with the DNA replication process and reducing the expression of the antiapoptotic marker Bcl-2. Ruthenium(II) half-sandwich complexes of 2-arylbenzothiazole and 2-picolyl linked by a 1,2,3-triazole bridge showed antiproliferative activity in the submicromolar range, displaying selectivity towards PANC1 cells. Acyl thiourea and benzothiazole conjugates and their Ru(II) complexes exhibited cytostatic activity in the low micromolar and nanomolar range against H460, MCF-7, SW 620 and HepG2 cells, with prominent activity against the MCF-7 breast cancer cell line. Besides, compounds showed weak to moderate antibacterial activity against E. faecalis. Ligand E5c and complexes D4aRu, E4cRu and E5cRu were selected for further evaluation of their mechanism of biological action.
Keywords
N-heterocikli
metalni kompleksi
organometalni kompleksi
antiproliferativno djelovanje
antibakterijsko djelovanje
Keywords (english)
N-heterocycles
metal complexes
organometallic complexes
antiproliferative activity
antibacterial activity
Language croatian
URN:NBN urn:nbn:hr:149:338635
Promotion 2023
Project Number: KK.01.1.1.04.0013 Title: Inovativna rješenja u katalitičkim proizvodnim procesima za potrebe farmaceutske industrije Title: Innovative solutions in catalytic processes in the pharmaceutical industry Acronym: CAT PHARMA Leader: Srećko Kirin Jurisdiction: eu Funder: EC Funding stream: EFRR
Study programme Title: Chemical Engineering and Applied Chemistry - Doctoral course Study programme type: university Study level: postgraduate Academic / professional title: doktor/doktorica znanosti u području prirodnih znanosti (doktor/doktorica znanosti u području prirodnih znanosti)
Type of resource Text
Extent 277 str. ; 30 cm
File origin Born digital
Access conditions Embargoed access Embargo expiration date: 2026-03-30
Terms of use
Created on 2023-05-08 07:29:10